SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-006056
Filing Date
2017-06-01
Accepted
2017-06-01 09:02:34
Documents
5
Period of Report
2017-06-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 32829
2 ex4-1.htm EX-4.1 120408
3 ex4-2.htm EX-4.2 121536
4 ex10-1.htm EX-10.1 49613
5 image_001.jpg GRAPHIC 11937
  Complete submission text file 0001493152-17-006056.txt   342189
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27072 | Film No.: 17883400
SIC: 2836 Biological Products, (No Diagnostic Substances)